MARATTO

article · IAES International Journal of Artificial Intelligence

Machine learning algorithms for breast cancer analysis: performance and accuracy comparison

Abstract

Breast cancer, a leading cause of cancer mortality among women, necessitates early detection to improve survival rates. Traditional diagnostics face accuracy and speed limitations, prompting this study to explore machine learning for enhanced diagnostics. We applied bidirectional encoder representations from transformers (BERT), long short-term memory (LSTM), naive Bayes, support vector machine (SVM), and random forest to the Breast Cancer Wisconsin dataset, implementing a thorough methodology involving data preprocessing, feature extraction, and model validation. BERT led in accuracy at 92.5%, showcasing advanced algorithms' potential in medical diagnostics, with random forest 90.6%, SVM 89.3%, LSTM 88.7%, and naive Bayes 85.2%; also showing promising results. The study underscores the importance of incorporating machine learning, especially BERT, into clinical decision-making, potentially revolutionizing breast cancer diagnostics by improving accuracy and efficiency. We recommend healthcare practitioners integrate these algorithms into their diagnostic processes. Future research should reeefine these algorithms and extend their application to enhance patient care further.

Research topics

  • AI in cancer detection
  • Radiomics and Machine Learning in Medical Imaging
  • Artificial Intelligence in Healthcare

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.11591/ijai.v13.i4.pp4372-4379

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.